GlassScriptPhysician profile
M Catherine Slusher
NPI 1073612958
$1,699.77
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456 · 2020: $242 · 2021: $395 · 2022: $264 · 2023: $307 · 2024: $35.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $429.52 | 2019-2022 | |
| Novo Nordisk INC | $352.38 | 2019-2023 | Wegovy |
| Currax Pharmaceuticals LLC | $161.89 | 2019-2022 | |
| Abbvie INC. | $116.60 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $108.02 | 2020-2023 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $102.96 | 2019-2023 | |
| Organon LLC | $70.12 | 2022-2023 | Nexplanon |
| Coopersurgical, INC. | $48.88 | 2021 | |
| Merck Sharp & Dohme LLC | $40.01 | 2019-2021 | |
| Lilly USA, LLC | $35.92 | 2024 | Zepbound |
| Therapeuticsmd, INC. | $35.86 | 2019-2022 | |
| Avion Pharmaceuticals | $26.89 | 2020-2021 | |
| Mycovia Pharmaceuticals, INC. | $25.96 | 2022-2023 | Vivjoa |
| Pfizer INC. | $24.33 | 2019 | |
| Urovant Sciences INC | $23.38 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $22.69 | 2019 | |
| Allergan, INC. | $18.32 | 2019 | |
| Becton, Dickinson and Company | $15.59 | 2019 | |
| Organogenesis INC. | $14.77 | 2019 | |
| Agile Therapeutics, INC. | $13.34 | 2021 | |
| Teleflex LLC | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw M Catherine Slusher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.